相关实验视频
Updated: Jun 11, 2026

12:43
On-Chip Endothelial Inflammatory Phenotyping
Published on: July 21, 2012
辛巴斯塔丁可以防止炎症期间的血管过活
Johannes Pleiner1, Georg Schaller, Friedrich Mittermayer
1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Circulation
|November 3, 2004
概括
高剂量的simvastatin在内毒性病期间防止了血管过活. 这种他类药物治疗保留了血管功能,并减少了健康志愿者的炎症标志物,表明了血管保护作用.
科学领域:
- 心血管药理学心血管药理学
- 炎症和免疫学 炎症和免疫学
- 内皮细胞功能 内皮细胞功能
背景情况:
- 类药物除了降脂之外,还具有抗炎和抗氧化特性.
- 在炎症期间观察到血管对乙胆 (ACh) 和上腺素 (NE) 的低活性.
研究的目的:
- 调查simvastatin是否可以在急性实验性炎症期间防止血管对ACh和NE的低活性.
主要方法:
- 在20名健康志愿者中进行了一项随机的,安慰剂控制的研究.
- 测量了前臂血流 (FBF) 对NE,ACH和酸甘油 (NTG) 的反应.
- 炎症是使用大肠杆菌内毒素 (脂聚糖 (LPS)) 诱导的.
主要成果:
- 使用LPS可以降低FBF对NE (43%) 和ACH (48%) 的反应,但不能降低NTG的反应.
- 辛巴斯塔丁 (80毫克) 完全保留了FBF对NE和ACH的反应.
- 西姆瓦斯塔丁缓解了中性粒细胞氧化突发和TNF-alpha.LPS诱导的增加.
结论:
- 高剂量的simvastatin在内毒性病期间表现出强大的血管保护作用.
- 这些发现表明,simvastatin在治疗急性系统性炎症中的血管过活性的有用性.
相关概念视频
Inflammatory Response I: Vascular and Cellular
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

